Today's Most Popular
Food and Drug Administration Reviews Antibiotic Active Against MRSA 
AHRQ Issues New Health IT Funding Opportunities - Genotype Analysis Adds Little to Ability to Predict Type 2 Diabetes
Annual Behavioral Health Care Conference 
Philips announces new 'iPill' - ICW, Cisco team up for rollout of smart healthcare card abroad
Physician Assistant - ADVANCE for Physician Assistants 
Bio Informatics News - Health Industry News - New Look and Feel
- The Joint Commission Names Recipients of 2008 Ernest Amory Codman Awards
Food and Drug Administration Reviews Antibiotic Active Against MRSA
Article posted from Americal College of Emergency Physicians (http://www.acep.org/NewsFeed.aspx?id=imn112020080045337730)
Americal College of Emergency Physicians (http://www.acep.org/NewsFeed.aspx?id=imn112020080045337730)
College Park, Md. (EGMN) -- A Food and Drug Administration advisory panel voted 10 to 8 that the data from two clinical trials of the antibiotic oritavancin failed to show it is an effective and safe treatment for complicated skin and skin structure infections, citing that more evidence is needed to prove its efficacy against methicillin-resistant .
More Stories in Americal College of Emergency Physicians
- Study Predicts Shortfall of More Than 1,000 Gastroenterologists by 2020
- Gene Alteration Predicts Risk in Childhood Acute Lymphoblastic Leukemia
- Early Elective Repeat C-Section Found Common, Harmful
- Concern About Potential Medication Harm Related to Underuse Among Diabetes Patients
- Deep Brain Stimulation Bests Medical Therapy for Advanced Parkinson's
Other Feedables
Web News - Everything Web
Famous Feedables - A juicy morsel of dish.
Womens Health - Healthy Feeding
Belle - For the feminine palette.
Tech Sale Feeds - A bargain buffet- more Feedables...